期刊
CURRENT ISSUES IN MOLECULAR BIOLOGY
卷 45, 期 7, 页码 5575-5597出版社
MDPI
DOI: 10.3390/cimb45070352
关键词
melanoma; molecular biology; genetics; clinical implications
Most young patients with advanced skin tumors die from melanoma, but modern treatments have improved survival rates. However, managing advanced stage melanoma remains difficult due to the lack of long-lasting response to initial treatment and the absence of randomized clinical trials in post immunotherapy/targeted molecular therapy settings.
Almost every death in young patients with an advanced skin tumor is caused by melanoma. Today, with the help of modern treatments, these patients survive longer or can even achieve a cure. Advanced stage melanoma is frequently related with poor prognosis and physicians still find this disease difficult to manage due to the absence of a lasting response to initial treatment regimens and the lack of randomized clinical trials in post immunotherapy/targeted molecular therapy settings. New therapeutic targets are emerging from preclinical data on the genetic profile of melanocytes and from the identification of molecular factors involved in the pathogenesis of malignant transformation. In the current paper, we present the diagnostic challenges, molecular biology and genetics of malignant melanoma, as well as the current therapeutic options for patients with this diagnosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据